Title - To study the clinical course and outcomes of non-electively hospitalised patients of chronic liver disease (CLD) with Hepatic or Extra-hepatic predominant organ failure(s) at 6 months.
Summary - ACLF is a condition where acute insult leading to worsening liver failure with or without extra-hepatic failure leads to a high short-term mortality. However, the presence of cirrhosis, prior decompensation, non-hepatic/systemic acute insult, organ failure and treatment are different in different part of the world. This is due to in-homogenous patient cohort. The current study was planned for all patients of CLD, who were non-electively hospitalized and were followed up for long-term to identify the differences in clinical course, acute insult, organ failure, therapy and outcome in relation to liver failure with or without extra-hepatic organic failure. In the study the laboratory, clinical parameters, inflammatory and regenerative markers will be evaluated as a marker of disease progression, reversal, recompensation or regression. This will enable us to differentiate the ACLF between east and west, guide us for defining the natural course of CLD with failure.
Age 18-70 years
CLD with or without cirrhosis with 1st or subsequent admissions for decompenasation and irrespective of any prior decompensation
Non-electively hospitalized
HCC
NCPF/EHPVO
Pregnancy
Post-Liver transplant
Chronic Liver Disease with or without cirrhosis, non-electively hospitalized with decompensation, hepatic and/or extra-hepatic organ failure with/without prior decompensation.
Cohort
Prospective
No Intervention
Other interventionNo Intervention
Death or liver transplant at 6 months follow up.
Recovery as per disease severity scores, i.e- decrease in MELD ≥5 and CTP ≥3
Organ dysfunction and organ failures
Click on the lead sponsor to view all of their trials.
